The rate of IFN production by infected cells was also predicted to be highest in mild patients in the COVID-19 reference virtual patient cohort as compared to the other two virtual patient cohorts, again showing the significant role of IFN in coordinating a sufficient immune defense against SARS-CoV-2 infection. This evidence concerns the gene IFNA1 and COVID-19.